-transparent.png){kind=logo}
OBJECTIVE To identify risk factors for Klebsiella pneumoniae bloodstream infections (BSI) in neonates in a hospital in the Kingdom of Saudi Arabia (KSA). METHODS Two case-control studies among hospitalized neonates during February 15-May 14, 1991, and a procedural and microbiological investigation. METHODS Hospital A, a maternity and children's hospital in KSA. METHODS Case patients had a blood culture positive for K pneumoniae after >2 days of hospitalization and had no evidence of a nonblood primary site of infection. RESULTS When the 20 case patients were compared with controls, hospitalization in a critical-care unit (odds ratio [OR], 5.5; 95% confidence interval [CI95], 1.20-51.1; P=.03) was identified as a risk factor. When the case patients were compared with a second set of controls matched by critical-care status, receipt of a particular intravenous fluid (D10%/0.2NS; OR, 11.0; CI95, 1.42-85.2; P=.009) or a blood product (OR undefined; P=.04) were identified as risk factors. Infusates were administered via umbilical catheters for most case and control patients (19/20 vs 15/20, P>.05); catheters were manipulated more frequently in patients in critical-care units. Umbilical catheter tip, skin, or mucus membrane K pneumoniae colonization occurred in 47% and 53% of evaluated case and control patients, respectively. Available K pneumoniae isolates from blood cultures and colonization sites had identical antimicrobial susceptibility patterns. Emphasis on handwashing, careful preparation and administration of infusates, and aseptic technique for catheter insertion, maintenance, and manipulation was temporally associated with resolution of the epidemic. CONCLUSIONS This outbreak was probably due to infusion therapy practices that led to BSI in nursery patients colonized with K pneumoniae. Both catheter-related infections and extrinsic contamination of infusates may have occurred. Hospital personnel should be aware of their potential to spread nosocomial pathogens from person to person and should implement Centers for Disease Control and Prevention recommendations to decrease nosocomial BSIs.
A A Al-Rabea, and
D R Burwen, and
M A Eldeen, and
R E Fontaine, and
F Tenover, and
W R Jarvis
July 2023,
Scientific reports,
A A Al-Rabea, and
D R Burwen, and
M A Eldeen, and
R E Fontaine, and
F Tenover, and
W R Jarvis
March 2004,
Infection control and hospital epidemiology,
A A Al-Rabea, and
D R Burwen, and
M A Eldeen, and
R E Fontaine, and
F Tenover, and
W R Jarvis
August 2020,
Cureus,
A A Al-Rabea, and
D R Burwen, and
M A Eldeen, and
R E Fontaine, and
F Tenover, and
W R Jarvis
September 2014,
Journal of infection in developing countries,
A A Al-Rabea, and
D R Burwen, and
M A Eldeen, and
R E Fontaine, and
F Tenover, and
W R Jarvis
January 2012,
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
A A Al-Rabea, and
D R Burwen, and
M A Eldeen, and
R E Fontaine, and
F Tenover, and
W R Jarvis
April 2023,
Microorganisms,
A A Al-Rabea, and
D R Burwen, and
M A Eldeen, and
R E Fontaine, and
F Tenover, and
W R Jarvis
February 2007,
Saudi medical journal,
A A Al-Rabea, and
D R Burwen, and
M A Eldeen, and
R E Fontaine, and
F Tenover, and
W R Jarvis
October 2013,
Expert review of anti-infective therapy,
A A Al-Rabea, and
D R Burwen, and
M A Eldeen, and
R E Fontaine, and
F Tenover, and
W R Jarvis
October 2023,
The Journal of antimicrobial chemotherapy,
A A Al-Rabea, and
D R Burwen, and
M A Eldeen, and
R E Fontaine, and
F Tenover, and
W R Jarvis
December 2012,
Saudi medical journal,
